Yes!  As a pediatric rheumatology community, we are very hopeful about the effectiveness of our medications and physical rehabilitation as we are successfully able to achieve remission for the majority of our patients. Recent data from research on Canadian children with arthritis has shown that more than 75% of patients will be in remission within 2 years of diagnosis and depending on the subtype this number may be higher.  Furthermore, one half of patients are able to stop medications within 5 years of diagnosis.  Depending on the subtype, however, some children will have to restart medications within 1-2 years of stopping them because of disease flare.  This risk is highest in patients with polyarthritis who have a positive rheumatoid factor; 2/3 of these patients will have to restart medications within the year of stopping. The goal for each patient is to achieve disease remission and thrive in their physical, social and emotional development. For some patients, this will be whilst taking medications long term but for others this may be achieved with medications and maintained after stopping medications. Being able to predict which children will be able to successfully stop medications particularly biologics is an active area of research in our community.